Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Collplant Biotechnologies Ltd ADR (CLGN)

Collplant Biotechnologies Ltd ADR (CLGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE PR Newswire - Thu Mar 26, 7:30AM CDT

REHOVOT, Israel , March 26, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on...

CLGN : 0.3391 (+0.03%)
CollPlant Biotechnologies Receives Nasdaq Notification Regarding Minimum Bid Requirement PR Newswire - Tue Mar 24, 3:01PM CDT

REHOVOT, Israel , March 24, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its...

CLGN : 0.3391 (+0.03%)
CollPlant Biotechnologies Launches Redesigned Corporate Website PR Newswire - Wed Mar 18, 8:00AM CDT

REHOVOT, Israel , March 18, 2026 /PRNewswire/ -- CollPlant (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its proprietary...

CLGN : 0.3391 (+0.03%)
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTS PR Newswire - Wed Mar 11, 7:00AM CDT

REHOVOT, Israel , March 11, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based...

CLGN : 0.3391 (+0.03%)
CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler PR Newswire - Thu Feb 26, 7:00AM CST

REHOVOT, Israel , Feb. 26, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on...

CLGN : 0.3391 (+0.03%)
CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex PR Newswire - Mon Feb 23, 6:00AM CST

REHOVOT, Israel , Feb. 23, 2026 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its proprietary...

CLGN : 0.3391 (+0.03%)
CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments PR Newswire - Tue Feb 17, 6:00AM CST

Next-generation rhCollagen-based technology aims to restore facial structure and skin quality in patients experiencing volume depletion linked to GLP-1 weight-loss therapies

CLGN : 0.3391 (+0.03%)
COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERING PR Newswire - Thu Feb 5, 7:00AM CST

REHOVOT, Israel , Feb. 5, 2026 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its...

CLGN : 0.3391 (+0.03%)
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE PR Newswire - Wed Nov 26, 2025

REHOVOT, Israel , Nov. 26, 2025 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its...

CLGN : 0.3391 (+0.03%)
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS PR Newswire - Tue Nov 18, 2025

REHOVOT, Israel , Nov. 18, 2025 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its...

CLGN : 0.3391 (+0.03%)

Barchart Exclusives

Should You Chase the Rally in Royal Caribbean Stock Today? Barchart - 9 minutes ago
Royal Caribbean stock rallies as Pakistan brokers a ceasefire between the U.S. and Iran. JPMorgan recommends owning RCL shares in 2026. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.